| URL | https://fortune.com/2019/10/17/trump-tariffs-china |
| Source | Fortune |
| Date Published | 10/17/2019 |
| Author Name | Shawn Tully |
| Mentions specific company case(s) of reshoring, kept from offshoring, or transplant | Yes |
| Company/Division name | DealMed |
| Parent company | DealMed |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Country(ies) from which reshored: | China |
| If relevant, work nearshored to: | - |
| Industry(ies): | Medical Equipment & Supplies |
| Product(s) reshored | medical supplies |
| What non-domestic negative factors made offshoring less attractive? | Tariffs |
| What domestic positive factors made reshoring more attractive? | Eco-system synergies, Government Incentives, tariffs |